Known unknowns.
The groundwork is currently being paved for the next generation of pharmacological treatments, which will improve quality of life with increasing efficiency. For example, contrary to previous thought, it is now known that the adult brain does to some extent grow new neurons—the study of which, in addition to neurotrophic factors, may hold hope for neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and types of chorea.
Learn more about CBD and the classical and non-classical psychedelic compounds that have been the subject of significant research in recent decades.
Global Partnerships.
Flow belongs to a global network of scientific and commercial organisations that has been involved in multiple clinical and preclinical studies and publications that are currently completed or underway, including randomized clinical trials, observation studies and case studies.
Many of these studies are conducted in partnership with academic research institutions and world renowned hospitals. We leverage our cannabis science expertise to cultivate new and unique cultivars, helping us stay ahead of evolving consumer demands.
The FlowLife App.
Use our app to connect with doctors, get advise on the right strains, ratios, etc. that will best help you with your condition. Available in March 2023.
Aurora Cannabis is a leading integrated cannabis company with a robust network of subsidiaries and strategic partnerships. With state-of-the-art production facilities Aurora operates around the globe pursuing new and emerging cannabis markets.